Hemoglobin A1c Testing Devices are used for diagnosis and monitoring of type 1 and type 2 diabetes. Hemoglobin A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Increasing prevalence of diabetes is expected to propel growth of the global hemoglobin A1c testing devices market over the forecast period.
Furthermore, increasing geriatric population, increasing healthcare infrastructure, and high prevalence of undiagnosed diabetes in emerging economies is also expected to propel the market growth during the forecasted period.
- This report provides in-depth analysis of the Hemoglobin A1c Testing Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global Hemoglobin A1c Testing Devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter), Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global Hemoglobin A1c Testing Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Hemoglobin A1c Testing Devices market
-
- Laboratory Testing Devices
- Point-of-care Testing Devices
-
- Ion-Exchange HPLC
- Immunoassay
- Boronate Affinity Chromatography
- Direct Enzymatic Assay
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
-
- Abbott Laboratories
- ARKRAY, Inc.
- Bio-Rad Laboratories, Inc.
- Chek Diagnostics (Polymer Technology Systems, Inc.)
- Danaher Corporation (Beckman Coulter)
- Hoffmann-La Roche Ltd.
- Menarini Group
- Sebia
- Siemens Healthcare
- Tosoh Corporation
- Trinity Biotech plc.
